165 related articles for article (PubMed ID: 23642455)
21. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity.
Betancor-Fernández A; Pérez-Gálvez A; Sies H; Stahl W
J Pharm Pharmacol; 2003 Jul; 55(7):981-6. PubMed ID: 12906755
[TBL] [Abstract][Full Text] [Related]
22. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
Stewart KM; Cole D
J Ethnopharmacol; 2005 Sep; 100(3):225-36. PubMed ID: 16112533
[TBL] [Abstract][Full Text] [Related]
23. Isolation and anti-inflammatory activity evaluation of triterpenoids and a monoterpenoid glycoside from Harpagophytum procumbens.
Qi J; Li N; Zhou JH; Yu BY; Qiu SX
Planta Med; 2010 Nov; 76(16):1892-6. PubMed ID: 20577946
[TBL] [Abstract][Full Text] [Related]
24. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.
Joshi K; Parrish A; Grunz-Borgmann EA; Gerkovich M; Folk WR
BMC Complement Med Ther; 2020 Jan; 20(1):9. PubMed ID: 32020872
[TBL] [Abstract][Full Text] [Related]
25. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
Hostanska K; Melzer J; Rostock M; Suter A; Saller R
J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
[TBL] [Abstract][Full Text] [Related]
26. LC-DAD-MS/SPE-NMR hyphenation. A tool for the analysis of pharmaceutically used plant extracts: identification of isobaric iridoid glycoside regioisomers from Harpagophytum procumbens.
Seger C; Godejohann M; Tseng LH; Spraul M; Girtler A; Sturm S; Stuppner H
Anal Chem; 2005 Feb; 77(3):878-85. PubMed ID: 15679357
[TBL] [Abstract][Full Text] [Related]
27. Physicochemical properties of harpagoside and its in vitro release from Harpagophytum procumbens extract tablets.
Chrubasik S; Sporer F; Dillmann-Marschner R; Friedmann A; Wink M
Phytomedicine; 2000 Jan; 6(6):469-73. PubMed ID: 10715851
[TBL] [Abstract][Full Text] [Related]
28. Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems.
Georgiev MI; Alipieva K; Orhan IE
Phytother Res; 2012 Feb; 26(2):313-6. PubMed ID: 21721061
[TBL] [Abstract][Full Text] [Related]
29. The influence of harpagoside and harpagide on TNFα-secretion and cell adhesion molecule mRNA-expression in IFNγ/LPS-stimulated THP-1 cells.
Schopohl P; Grüneberg P; Melzig MF
Fitoterapia; 2016 Apr; 110():157-65. PubMed ID: 26979254
[TBL] [Abstract][Full Text] [Related]
30. Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety.
Brien S; Lewith GT; McGregor G
J Altern Complement Med; 2006 Dec; 12(10):981-93. PubMed ID: 17212570
[TBL] [Abstract][Full Text] [Related]
31. High anti-inflammatory activity of harpagoside-enriched extracts obtained from solvent-modified super- and subcritical carbon dioxide extractions of the roots of Harpagophytum procumbens.
Günther M; Laufer S; Schmidt PC
Phytochem Anal; 2006; 17(1):1-7. PubMed ID: 16454469
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of degenerative diseases of the musculoskeletal system with South African devil's claw (Harpagophytum procumbens DC)].
Wegener T
Wien Med Wochenschr; 1999; 149(8-10):254-7. PubMed ID: 10483693
[TBL] [Abstract][Full Text] [Related]
33. From Bush Medicine to Modern Phytopharmaceutical: A Bibliographic Review of Devil's Claw (
Brendler T
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451822
[TBL] [Abstract][Full Text] [Related]
34. Fast HPLC for quality control of Harpagophytum procumbens by using a monolithic silica column: method transfer from conventional particle-based silica column.
Schmidt AH
J Chromatogr A; 2005 May; 1073(1-2):377-81. PubMed ID: 15909544
[TBL] [Abstract][Full Text] [Related]
35. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease.
Whitehouse LW; Znamirowska M; Paul CJ
Can Med Assoc J; 1983 Aug; 129(3):249-51. PubMed ID: 6407745
[TBL] [Abstract][Full Text] [Related]
36. Comparison between HPLC and HPTLC-densitometry for the determination of harpagoside from Harpagophytum procumbens CO(2)-extracts.
Günther M; Schmidt PC
J Pharm Biomed Anal; 2005 Apr; 37(4):817-21. PubMed ID: 15797807
[TBL] [Abstract][Full Text] [Related]
37. Quality Assessment of Commercial Spagyric Tinctures of
Avato P; Argentieri MP
Molecules; 2019 Jun; 24(12):. PubMed ID: 31212908
[TBL] [Abstract][Full Text] [Related]
38. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase.
Boje K; Lechtenberg M; Nahrstedt A
Planta Med; 2003 Sep; 69(9):820-5. PubMed ID: 14598207
[TBL] [Abstract][Full Text] [Related]
39. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.).
Wegener T; Lüpke NP
Phytother Res; 2003 Dec; 17(10):1165-72. PubMed ID: 14669250
[TBL] [Abstract][Full Text] [Related]
40. Antiinflammatory effects of different extracts and harpagoside isolated from Scrophularia frutescens L.
García D; Fernández A; Sáenz T; Ahumada C
Farmaco; 1996 Jun; 51(6):443-6. PubMed ID: 8766229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
